PIA
EVLO

Piedmont Investment Advisors’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Piedmont Investment Advisors’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5
Closed -$1K – 2493
2018
Q2 		$1K Buy
+5
New +$1.46K ﹤0.01% 2837

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Piedmont Investment Advisors's EVLO Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q3 2018, closing a stake of 5 shares — an estimated $1K sold.

Piedmont Investment Advisors first reported a position in EVLO in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 37 funds tracked by Wall St. Rank hold EVLO as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 5 Evelo Biosciences, Inc. Common Stock shares in Q3 2018, an estimated $1K.
  • Piedmont Investment Advisors first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Evelo Biosciences, Inc. Common Stock position peaked at $1K in Q2 2018.
  • 37 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.